This book offers a comprehensive overview of the latest breakthroughs transforming cancer research and treatment.
This book offers a comprehensive overview of the latest breakthroughs transforming cancer research and treatment. Integrating insights from molecular biology, pharmacology, microbiomics, and artificial intelligence, this volume highlights how cross-disciplinary innovations are redefining oncology.
The book explores the applications of multi-omics and computational tools, the potential of heterocyclic and bioactive compounds, and the promise of probiotic-based nanomedicine in advancing personalized cancer therapy. It further examines the emerging roles of the gut microbiome, pharmacomicrobiomics, and AI-driven diagnostics in enhancing therapeutic precision and enabling early cancer detection. Addressing a wide spectrum of cancer types from colorectal and breast cancers to gliomas, the book also discusses contemporary challenges such as microplastic exposure, mitochondrial dysfunction, and the importance of evidence-based clinical practices in oncology. Beyond therapeutics, it highlights cutting-edge diagnostic innovations, including AI-assisted screening tools and microbiome-based biomarkers for early colorectal cancer detection. The volume concludes with evidence-based insights into clinical practices, such as blood transfusion protocols in oncology, effectively bridging laboratory research with real-world clinical applications.
With contributions from leading experts across disciplines, this book serves as a valuable reference for oncologists, biomedical researchers, clinicians, and students, offering a forward-looking perspective on how integrated scientific approaches are shaping the future of cancer care.
Chapter 1: Multi-Omics, Computational Approaches, and AI Tools in
Oncotherapeutics: Recent Advances and Perspectives.
Chapter 2: Exploring
Small Heterocyclic Compounds as Promising Agents in Cancer Therapy.
Chapter
3: Probiotic-Based Nanomedicine: A Next-Generation Strategy for Personalized
Cancer Therapy.
Chapter 4: Pharmacomicrobiomics and AI designs in GI Tract
Cancers.
Chapter 5: Gut microbiome: a novel screening tool for colorectal
cancer.
Chapter 6: The Intersection of Oncology and Infectious Diseases in
Human Health: The Battle Between Pathogens.
Chapter 7: Artificial
intelligence-integrated precision oncology of colorectal cancer.
Chapter 8:
Precision Medicine in Breast Cancer: An Immuno-oncology Approach.
Chapter 9:
Harnessing probiotics for personalized cancer therapy: A holistic approach.
Chapter 10: Mitochondrial Dysfunction in Gliomas: Pathophysiological insights
and Therapeutic Targets.
Chapter 11: Plastic Pollution and Cancer: The
Emerging Role of Microplastics in Oncology.
Chapter 12: Bioactive Compounds
in Personalized Colorectal Cancer Therapy: Emerging Challenges and Future
Directions.
Chapter 13: Evidence based blood transfusion practices.
Surajit Pathak, Ph.D., is a leading researcher and academic, currently a Professor at Chettinad Academy of Research and Education in Chennai. He has previously held esteemed positions as Principal Research Scientist at Linkoping University, Sweden, With a Ph.D. from India (2007) and an extensive post-doctoral journey at renowned institutions such as the University of Alabama (USA), University of Padova (Italy), and University of Linkoping (Sweden), his research focuses on microRNAs for early colorectal cancer detection. Prof. Pathak has published over 150 research and review articles, earning more than 5000 citations (Google Scholar) and an h-index of 39. Prof. Pathak is a member of national research societies.
Antara Banerjee, Ph.D., is currently working as Professor at Chettinad Academy of Research and Education (CARE), Chennai. Dr. Banerjee pursued her post-doctoral research on Cancer Biology and Regenerative Medicine at the University of Padova, Italy, and Linkoping University. She has published over 120 articles with an h-index of 34 and 3804 citations (Google Scholar) with two patents awarded and five filed and secured national and international grants. Dr. Banerjee has edited several books on stem cells and cancer. She is affiliated with professional research bodies and is a member of several national research societies.
